SLSN Solesence Inc.

  1. Stocks
  2. Consumer Defensive
  3. NASDAQ: SLSN

Price (delayed)

$1.03

Market cap

$72.75M

P/E Ratio

51.5

Dividend/share

N/A

EPS

$0.02

Enterprise value

$94.46M

?
Relative Growth: Rel. Growth: 26
Relative Strength: Rel. Strength: 7
Relative Valuation: Rel. Valuation: 43
Relative Profitability: Rel. Profitability: 34

Nanophase Technologies Corporation, www.nanophase.com, is a leading innovator in mineral-based and scientifically driven healthcare solutions across beauty and life science categories, as well as other legacy advanced materials applications. Leveraging ...

Highlights
SLSN's price to earnings (P/E) is 58% less than its last 4 quarters average of 121.3
The debt has declined by 8% since the previous quarter
The quick ratio has soared by 67% YoY but it has contracted by 5% from the previous quarter
The equity rose by 12% YoY but it fell by 3.8% QoQ
SLSN's net income has shrunk by 72% YoY and by 47% QoQ
Solesence's EPS has plunged by 60% YoY and by 33% from the previous quarter
Sector: Consumer Defensive
Industry: Household & Personal Products
Website: https://solesence.com
Peers: PG CL KMB EL

Key stats

What are the main financial stats of SLSN

SLSN stock price

How has the Solesence stock price performed over time
Intraday
-3.74%
1 week
25.61%
1 month
43.12%
1 year
-66.12%
YTD
-35.42%
QTD
40.14%

Financial performance

How have Solesence's revenue and profit performed over time
Revenue
$60.4M
Gross profit
$16.02M
Operating income
$2.03M
Net income
$944,000
Gross margin
26.5%
Net margin
1.6%
The net margin has dropped by 73% year-on-year and by 45% since the previous quarter
SLSN's net income has shrunk by 72% YoY and by 47% QoQ
The operating margin has dropped by 55% year-on-year and by 24% since the previous quarter
The operating income has plunged by 52% YoY and by 27% from the previous quarter

Price vs fundamentals

How does SLSN's price correlate with its fundamentals

Growth

What is Solesence's growth rate over time

Valuation

What is Solesence stock price valuation
SLSN P/E details
P/E
51.5
P/B
4.29
P/S
1.2
EV/EBIT
46.44
EV/EBITDA
31.3
EV/Sales
1.56
Solesence's EPS has plunged by 60% YoY and by 33% from the previous quarter
SLSN's price to earnings (P/E) is 58% less than its last 4 quarters average of 121.3
SLSN's P/B is 68% below its 5-year quarterly average of 13.2 and 58% below its last 4 quarters average of 10.1
The equity rose by 12% YoY but it fell by 3.8% QoQ
The P/S is 59% below the 5-year quarterly average of 2.9 and 57% below the last 4 quarters average of 2.8
Solesence's revenue has increased by 6% YoY but it has decreased by 2.7% from the previous quarter

Efficiency

How efficient is Solesence business performance
The ROE has plunged by 77% YoY and by 49% from the previous quarter
Solesence's ROA has plunged by 74% YoY and by 44% from the previous quarter
The return on invested capital has dropped by 67% year-on-year and by 32% since the previous quarter
Solesence's ROS has plunged by 55% YoY and by 24% from the previous quarter

Dividends

What is SLSN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SLSN.

Financial health

How did Solesence financials performed over time
The total assets is 55% more than the total liabilities
Solesence's current ratio has soared by 91% YoY
The quick ratio has soared by 67% YoY but it has contracted by 5% from the previous quarter
The debt is 31% greater than the equity
The company's debt to equity fell by 12% YoY and by 5% QoQ
The equity rose by 12% YoY but it fell by 3.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.